mrna-based

Moderna files for U.S. clearance of mRNA-based flu shot

Today we provided an update on regulatory submissions for our investigational seasonal influenza vaccine, mRNA-1010, for adults aged 50 years and older. Moderna has filed for marketing authorization with the U.S. Food and Drug Administration, the European Medicines Agency, Health… pic.twitter.com/EQzOMTemq8 — Moderna (@moderna_tx) January 5, 2026 Moderna (MRNA) shares traded higher on Monday after …

READ MORE

Uh-oh! It looks like you're using an ad blocker.

Our website relies on ads and the generous support of readers like you to keep delivering free, high-quality content. Right now, we are facing serious funding challenges and we need your help more than ever. Disable your ad blocker and this message will vanish. You can also sign up for a membership to enjoy an ad-free experience while supporting our work: https://citizenwatchreport.com/plans/subscriptions/ Your support helps us stay independent, continue our work, and keep content free for everyone. We truly appreciate your understanding and thank you for standing with us.